Point72 Middle East Fze Bristol Myers Squibb CO Call Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $1.7 Million - $2.03 Million	-35,100 Reduced 38.4%	56,300 $2.89 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $1.07 Million - $1.2 Million	18,500 Added 25.38%	91,400 $5.3 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $2.64 Million - $2.94 Million	41,500 Added 132.17%	72,900 $4.66 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $7.91 Million - $8.97 Million	-120,400 Reduced 79.31%	31,400 $2.18 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $10.4 Million - $12.3 Million	151,800 New	151,800 $0

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.